marketcaparena
Search

    TGTX

    TG THERAPEUTICS, INC.

    Company overview

    Market capitalization
    $8.60B
    Employees
    399
    Latest publication
    2026-09-29
    About TG THERAPEUTICS, INC.

    TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue240,335,000USD204,918,000USD192,574,000USD161,709,000USD141,148,000USD120,856,000USD108,185,000USD83,879,000USD
    Cost Of Revenue41,194,000USD33,510,000USD38,142,000USD28,155,000USD18,938,000USD15,541,000USD15,399,000USD9,341,000USD
    Gross Profit199,141,000USD171,408,000USD154,432,000USD133,554,000USD122,210,000USD105,315,000USD92,786,000USD74,538,000USD
    Research Development95,337,000USD43,521,000USD41,193,000USD40,878,000USD31,782,000USD46,362,000USD23,874,000USD20,138,000USD
    Selling General Administrative82,130,000USD88,217,000USD62,745,000USD63,373,000USD55,585,000USD50,331,000USD38,963,000USD41,966,000USD
    Total Operating Expenses177,467,000USD136,613,000USD103,938,000USD104,189,000USD87,367,000USD96,693,000USD62,837,000USD62,104,000USD
    Operating Income21,674,000USD34,795,000USD50,494,000USD29,365,000USD34,843,000USD8,622,000USD29,949,000USD12,434,000USD
    Total Other Income Expense Net-11,440,000USD-14,432,000USD-5,401,000USD-3,456,000USD-3,923,000USD-3,154,000USD-4,496,000USD-8,166,000USD
    Interest Expense16,572,000USD7,666,000USD6,533,000USD6,721,000USD6,716,000USD6,757,000USD7,061,000USD10,832,000USD
    Income Before Tax10,234,000USD20,363,000USD45,093,000USD25,909,000USD30,920,000USD5,468,000USD25,453,000USD4,268,000USD
    Income Tax Expense2,453,000USD586,000USD22,056,000USD-364,986,000USD2,733,000USD408,000USD2,122,000USD388,000USD
    Net Income7,781,000USD19,777,000USD23,037,000USD390,895,000USD28,187,000USD5,060,000USD23,331,000USD3,880,000USD
    Unclassified Operating Expenses—4,875,000USD——————
    Net Interest Income—-7,666,000USD-6,533,000USD-6,721,000USD-6,716,000USD-6,757,000USD-7,061,000USD-10,832,000USD
    Tax Provision—586,000USD22,056,000USD-364,986,000USD2,733,000USD408,000USD2,122,000USD388,000USD
    Net Income From Continuing Ops—19,777,000USD23,037,000USD390,895,000USD28,187,000USD5,060,000USD23,331,000USD3,880,000USD
    Ebit—28,029,000USD51,626,000USD32,630,000USD37,636,000USD12,225,000USD32,514,000USD15,100,000USD
    Ebitda—28,109,000USD51,693,000USD32,692,000USD37,695,000USD12,281,000USD32,576,000USD15,164,000USD
    Depreciation And Amortization—80,000USD67,000USD62,000USD59,000USD56,000USD62,000USD64,000USD
    Reconciled Depreciation—80,000USD67,000USD62,000USD59,000USD56,000USD62,000USD64,000USD
    Selling And Marketing Expenses——————154,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue616,287,000USD329,004,000USD233,662,000USD152,000USD152,381USD152,381USD152,381USD152,381USD
    Cost Of Revenue100,714,000USD38,486,000USD14,131,000USD88,000USD118,781,000USD79,058,000USD63,317,000USD55,869,000USD
    Gross Profit515,573,000USD290,518,000USD219,531,000USD64,000USD152,381USD152,381USD152,381USD152,381USD
    Research Development160,215,000USD94,291,000USD76,192,000USD153,793,000USD96,886,134USD66,489,820USD43,445,817USD31,354,781USD
    Selling General Administrative232,034,000USD154,298,000USD122,706,000USD15,161,000USD21,977,998USD12,631,689USD15,625,174USD15,787,126USD
    Total Operating Expenses392,249,000USD248,589,000USD198,898,000USD174,552,000USD118,864,132USD79,121,509USD63,332,397USD55,873,473USD
    Operating Income123,324,000USD41,929,000USD20,633,000USD-174,400,000USD-118,711,751USD-78,969,128USD-63,180,016USD-55,721,092USD
    Interest Expense26,727,000USD24,028,000USD12,615,000USD1,734,000USD1,139,478USD0USD972,736USD930,701USD
    Net Interest Income-26,727,000USD-24,028,000USD-12,615,000USD857,000USD294,478USD323,032USD——
    Income Before Tax107,390,000USD25,594,000USD13,062,000USD-173,482,000USD-118,476,012USD-78,252,894USD-62,948,646USD-55,781,277USD
    Income Tax Expense-339,789,000USD2,211,000USD390,000USD-918,000USD-235,739USD-716,234USD-231,370USD60,185USD
    Tax Provision-339,789,000USD2,211,000USD390,000USD—————
    Net Income447,179,000USD23,383,000USD12,672,000USD-173,482,000USD-118,476,012USD-78,252,894USD-62,948,646USD-55,781,277USD
    Net Income From Continuing Ops447,179,000USD23,383,000USD12,672,000USD-173,482,000USD-118,476,012USD-78,252,894USD-62,948,646USD-55,781,277USD
    Ebit134,117,000USD49,622,000USD25,677,000USD-173,482,000USD-118,711,751USD-78,969,128USD-63,180,016USD-55,721,092USD
    Ebitda134,361,000USD49,902,000USD26,100,000USD-173,394,000USD-118,629,396USD-78,906,168USD-63,164,564USD-55,717,161USD
    Depreciation And Amortization244,000USD280,000USD423,000USD88,000USD82,355USD62,960USD15,452USD3,931USD
    Reconciled Depreciation244,000USD280,000USD423,000USD88,000USD82,355USD———
    Total Other Income Expense Net-15,934,000USD-16,335,000USD-7,571,000USD918,000USD-58,739USD393,202USD231,370USD-60,185USD
    Selling And Marketing Expenses———5,598,000USD——4,261,406USD8,731,566USD
    Interest Income———857,000USD294,478USD323,032USD231,370USD—
    Non Operating Income Net Other———918,000USD235,739USD716,234USD1,204,106USD870,516USD
    Net Income Applicable To Common Shares———-173,482,000USD-118,476,012USD-78,252,894USD-62,948,646USD-55,781,277USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,639,629,000USD1,528,837,000USD1,063,253,000USD1,025,024,000USD702,613,000USD656,689,000USD577,690,000USD586,014,000USD
    Cash And Equivalents482,575,000USD———————
    Cash And Short Term Investments612,300,000USD514,429,999USD141,970,000USD131,582,000USD251,870,000USD276,240,000USD311,000,000USD341,041,000USD
    Short Term Investments69,673,000USD72,221,000USD62,822,000USD57,501,000USD122,744,000USD144,101,000USD131,106,000USD145,219,000USD
    Long Term Investments64,368,000USD87,884,000USD74,825,000USD48,757,000USD28,590,000USD1,907,000USD808,000USD1,125,000USD
    Total Current Assets1,145,687,000USD1,086,969,000USD630,764,000USD599,765,000USD663,962,000USD644,510,000USD566,359,000USD574,069,000USD
    Other Current Assets43,901,000USD51,464,000USD57,580,000USD55,846,000USD25,374,000USD20,390,000USD15,716,000USD32,632,000USD
    Other Non Current Assets2,211,000USD———————
    Total Liabilities1,035,546,000USD———————
    Total Current Liabilities268,493,000USD187,108,000USD153,760,000USD156,810,000USD171,889,000USD160,209,000USD90,679,000USD125,114,000USD
    Other Current Liabilities857,000USD———————
    Total Stockholder Equity604,083,000USD583,131,000USD648,020,000USD607,218,000USD276,432,000USD237,289,000USD222,364,000USD192,157,000USD
    Total Equity Including Noncontrolling Interest604,083,000USD———————
    Long Term Debt745,387,000USD745,140,000USD245,645,000USD245,340,000USD245,037,000USD244,733,000USD244,429,000USD244,158,000USD
    Deferred Revenue16,825,000USD———————
    Deferred Revenue Non Current14,525,000USD———————
    Net Receivables401,565,000USD392,046,000USD305,628,000USD265,384,000USD231,516,000USD190,121,000USD129,185,000USD115,727,000USD
    Inventory147,973,000USD129,029,000USD125,586,000USD146,953,000USD155,202,000USD157,759,000USD110,458,000USD84,669,000USD
    Property Plant Equipment Net7,085,000USD6,481,000USD6,278,000USD6,501,000USD6,718,000USD6,927,000USD7,151,000USD7,411,000USD
    Accounts Payable213,693,000USD148,845,000USD107,508,000USD112,336,000USD134,020,999USD133,932,000USD58,296,000USD101,407,000USD
    Short Term Debt1,913,000USD1,822,000USD1,044,000USD1,892,000USD1,091,000USD1,116,000USD1,157,000USD1,231,000USD
    Common Stock160,000USD160,000USD159,000USD159,000USD159,000USD159,000USD156,000USD156,000USD
    Retained Earnings-1,054,457,000USD-1,062,238,000USD-1,082,015,000USD-1,105,052,000USD-1,495,947,000USD-1,524,134,000USD-1,529,194,000USD-1,552,525,000USD
    Total Liab—945,706,000USD415,233,000USD417,806,000USD426,181,000USD419,400,000USD355,326,000USD393,857,000USD
    Other Current Liab—19,251,000USD23,974,000USD16,183,000USD146,887,000USD142,014,000USD78,108,000USD114,790,000USD
    Capital Stock—160,000USD159,000USD159,000USD159,000USD159,000USD156,000USD156,000USD
    Cash—442,209,000USD79,148,000USD74,081,000USD129,126,000USD132,139,000USD179,894,000USD195,822,000USD
    Current Deferred Revenue—17,190,000USD21,234,000USD26,399,000USD23,911,000USD17,079,000USD11,414,000USD9,093,000USD
    Net Debt—311,348,000USD181,583,000USD179,635,000USD124,590,000USD121,570,000USD73,825,000USD57,986,000USD
    Short Long Term Debt Total—753,557,000USD260,731,000USD253,716,000USD253,716,000USD253,709,000USD253,719,000USD253,808,000USD
    Property Plant Equipment Gross—6,481,000USD6,278,000USD6,501,000USD6,718,000USD6,927,000USD7,151,000USD7,411,000USD
    Common Stock Shares Outstanding—160,062,326shares159,366,352shares160,997,977shares162,559,404shares162,769,202shares160,244,430shares160,714,388shares
    Non Current Assets Total—441,867,999USD432,489,000USD425,259,000USD38,651,000USD12,178,000USD11,331,000USD11,945,000USD
    Non Current Liabilities Total—758,598,000USD261,473,000USD260,996,000USD254,292,000USD259,191,000USD264,647,000USD268,743,000USD
    Non Currrent Assets Other—28,360,999USD19,075,000USD3,374,000USD3,343,000USD3,344,000USD3,372,000USD3,409,000USD
    Net Working Capital—899,861,000USD477,004,000USD442,955,000USD492,073,000USD484,301,000USD475,680,000USD448,955,000USD
    Unclassified Non Current Assets—319,142,000USD332,311,000USD366,627,000USD————
    Unclassified Non Current Liabilities—13,458,000USD15,828,000USD15,656,000USD9,255,000USD14,458,000USD20,218,000USD24,585,000USD
    Unclassified Equity—1,645,049,000USD1,729,717,000USD1,711,952,000USD1,772,061,000USD1,761,105,000USD1,751,246,000USD1,744,370,000USD
    Unclassified Current Liabilities————-134,020,999USD-133,932,000USD-58,296,000USD-101,407,000USD
    Other Assets—————1,000USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,063,253,000USD577,690,000USD329,587,000USD193,572,000USD379,629,000USD625,642,000USD163,014,000USD83,616,000USD
    Other Current Assets57,580,000USD15,716,000USD9,519,000USD6,596,000USD14,813,000USD6,314,000USD8,716,000USD10,035,000USD
    Total Liab415,233,000USD355,326,000USD169,085,000USD134,985,000USD142,476,000USD106,292,000USD124,399,000USD59,580,000USD
    Total Stockholder Equity648,020,000USD222,364,000USD160,502,000USD58,587,000USD237,153,000USD519,350,000USD38,615,000USD24,036,000USD
    Other Current Liab23,974,000USD78,108,000USD52,122,000USD51,620,000USD62,972,000USD63,706,000USD82,833,000USD2,258,000USD
    Common Stock159,000USD156,000USD151,000USD146,000USD143,000USD141,000USD109,000USD84,000USD
    Capital Stock159,000USD156,000USD151,000USD146,000USD143,000USD141,000USD109,000USD84,000USD
    Retained Earnings-1,082,015,000USD-1,529,194,000USD-1,552,577,000USD-1,527,033,000USD-1,328,698,000USD-980,597,000USD-701,216,000USD-528,345,000USD
    Cash79,148,000USD179,894,000USD92,933,000USD102,304,000USD298,887,000USD553,439,000USD112,637,000USD41,958,000USD
    Cash And Short Term Investments141,970,000USD311,000,000USD217,508,000USD161,678,000USD314,763,000USD605,426,000USD140,435,000USD68,806,000USD
    Total Current Assets630,764,000USD566,359,000USD317,943,000USD168,274,000USD330,965,000USD611,740,000USD149,151,000USD79,031,000USD
    Total Current Liabilities153,760,000USD90,679,000USD53,720,000USD53,201,000USD65,384,000USD87,554,000USD84,449,000USD38,854,000USD
    Current Deferred Revenue21,234,000USD11,414,000USD152,000USD200,000USD457,000USD152,000USD47,352,000USD152,000USD
    Net Debt181,583,000USD73,825,000USD17,862,000USD-19,244,000USD-219,840,000USD-511,463,000USD-71,833,000USD-41,891,000USD
    Short Term Debt1,044,000USD1,157,000USD1,446,000USD1,581,000USD2,412,000USD23,848,000USD1,616,000USD67,000USD
    Short Long Term Debt Total260,731,000USD253,719,000USD110,795,000USD83,060,000USD79,047,000USD41,976,000USD40,804,000USD67,000USD
    Long Term Debt245,645,000USD244,429,000USD100,118,000USD71,135,000USD66,788,000USD7,716,000USD28,970,000USD—
    Long Term Investments74,825,000USD808,000USD0USD12,404,000USD35,533,000USD0USD——
    Short Term Investments62,822,000USD131,106,000USD124,575,000USD59,374,000USD15,876,000USD51,987,000USD27,798,000USD26,848,000USD
    Net Receivables305,628,000USD129,185,000USD51,093,000USD0USD1,389,000USD0USD—95,000USD
    Inventory125,586,000USD110,458,000USD39,823,000USD0USD-23,604,000USD——9,691,000USD
    Accounts Payable107,508,000USD58,296,000USD38,471,000USD42,019,000USD51,294,000USD37,014,000USD30,041,000USD36,377,000USD
    Property Plant Equipment Net6,278,000USD7,151,000USD8,145,000USD10,822,000USD11,068,000USD11,844,000USD11,813,000USD2,545,000USD
    Property Plant Equipment Gross6,278,000USD7,151,000USD9,560,000USD10,822,000USD11,068,000USD11,844,000USD11,813,000USD2,545,000USD
    Common Stock Shares Outstanding161,412,746shares160,336,000shares148,508,465shares135,411,258shares132,222,753shares115,333,693shares88,368,844shares75,466,813shares
    Non Current Assets Total432,489,000USD11,331,000USD11,644,000USD25,298,000USD48,664,000USD13,902,000USD13,863,000USD4,585,000USD
    Non Current Liabilities Total261,473,000USD264,647,000USD115,365,000USD81,784,000USD77,092,000USD18,738,000USD39,950,000USD20,726,000USD
    Non Currrent Assets Other19,075,000USD3,372,000USD1,415,000USD1,273,000USD1,264,000USD1,259,000USD1,251,000USD1,241,000USD
    Net Working Capital477,004,000USD475,680,000USD264,223,000USD115,073,000USD265,581,000USD524,186,000USD64,702,000USD40,177,000USD
    Unclassified Non Current Assets332,311,000USD—-328,302,000USD-2,900,000USD-3,103,000USD-13,103,000USD-3,380,000USD-3,535,000USD
    Unclassified Non Current Liabilities15,828,000USD20,218,000USD15,247,000USD————-20,726,000USD
    Unclassified Equity1,729,717,000USD1,751,246,000USD1,712,777,000USD1,585,328,000USD1,565,799,000USD1,499,899,000USD739,847,000USD552,447,000USD
    Good Will—799,000USD799,000USD799,000USD799,000USD799,000USD799,000USD799,000USD
    Unclassified Current Liabilities—-58,296,000USD-38,471,000USD-42,219,000USD-52,726,000USD-59,345,000USD-77,583,000USD—
    Other Assets——329,587,000USD2,900,000USD3,103,000USD13,103,000USD3,380,000USD3,535,000USD
    Accumulated Other Comprehensive Income——0USD0USD0USD0USD0USD0USD
    Deferred Long Term Liab———305,000USD457,000USD610,000USD762,000USD2,376,000USD
    Other Liab———305,000USD457,000USD610,000USD762,000USD20,726,000USD
    Non Current Liabilities Other———10,344,000USD9,847,000USD10,412,000USD10,218,000USD18,350,000USD
    Net Tangible Assets———57,788,000USD310,718,000USD518,551,000USD37,816,000USD23,237,000USD
    Short Long Term Debt————975,000USD22,179,000USD190,000USD67,000USD
    Treasury Stock————-234,000USD-234,000USD-234,000USD-234,000USD
    Unclassified Current Assets———————-9,596,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation85,000USD
    Stock Based Compensation47,825,000USD
    Deferred Income Tax4,572,000USD
    Other Non Cash Items-9,153,000USD
    Change To Account Receivables-95,937,000USD
    Change To Inventory-80,099,000USD
    Change To Liabilities97,484,000USD
    Change In Working Capital-88,214,000USD
    Operating Cash Flow21,369,000USD
    Capital Expenditures-344,000USD
    Unclassified Investing Cash Flow-8,490,000USD
    Investing Cash Flow-8,834,000USD
    Net Debt Issuance747,656,000USD
    Unclassified Financing Cash Flow-356,742,000USD
    Financing Cash Flow390,914,000USD
    Change In Cash403,449,000USD
    End Cash Flow483,939,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income19,777,000USD23,037,000USD390,895,000USD28,187,000USD5,060,000USD23,331,000USD3,880,000USD6,879,000USD
    Depreciation80,000USD7,523,000USD62,000USD59,000USD56,000USD62,000USD64,000USD72,000USD
    Stock Based Compensation19,950,000USD15,651,000USD17,686,000USD16,361,000USD14,972,000USD11,948,000USD11,773,000USD9,481,000USD
    Other Non Cash Items8,198,000USD-635,000USD-367,084,000USD-430,000USD-262,000USD-242,000USD3,903,000USD-231,000USD
    Change To Account Receivables-86,418,000USD-40,244,000USD-33,868,000USD-41,395,000USD-60,936,000USD-13,458,000USD-32,119,000USD-18,626,000USD
    Change To Inventory-13,275,000USD563,000USD8,695,000USD3,595,000USD-46,305,000USD-24,820,000USD-2,540,000USD-2,560,000USD
    Change In Working Capital-69,763,000USD-44,543,000USD-64,712,000USD-36,741,000USD-48,541,000USD-60,740,000USD-31,825,000USD-10,665,000USD
    Total Cash From Operating Activities-17,894,000USD19,660,000USD-23,153,000USD7,436,000USD-28,715,000USD-25,641,000USD-12,205,000USD5,536,000USD
    Capital Expenditures-51,000USD-67,000USD-80,000USD-42,000USD-25,000USD-21,000USD-24,000USD0USD
    Free Cash Flow-17,945,000USD19,593,000USD-23,233,000USD7,394,000USD-28,740,000USD-25,662,000USD-12,229,000USD5,536,000USD
    Investments-9,813,000USD-16,821,000USD47,693,000USD-3,992,000USD-12,934,000USD15,788,000USD-9,334,000USD1,765,000USD
    Total Cashflows From Investing Activities-9,864,000USD-15,638,000USD46,363,000USD-3,992,000USD-12,934,000USD15,788,000USD-9,334,000USD1,765,000USD
    Net Borrowings492,656,000USD0USD——0USD0USD137,262,000USD—
    Total Cash From Financing Activities390,829,000USD1,058,000USD-78,242,000USD-6,443,000USD-6,102,000USD-6,072,000USD134,454,000USD135,000USD
    Dividends Paid0USD———0USD———
    Sale Purchase Of Stock-99,992,000USD-19,121,000USD-78,242,000USD-6,875,000USD-6,123,000USD-6,611,000USD-2,149,000USD-1,000USD
    Change In Cash363,061,000USD5,080,000USD-55,032,000USD-2,999,000USD-47,751,000USD-15,925,000USD112,915,000USD7,433,000USD
    Begin Period Cash Flow79,148,000USD75,410,000USD130,442,000USD133,441,000USD181,192,000USD197,117,000USD84,202,000USD75,477,000USD
    End Period Cash Flow442,209,000USD80,490,000USD75,410,000USD130,442,000USD133,441,000USD181,192,000USD197,117,000USD82,910,000USD
    Other Cashflows From Investing Activities-9,813,000USD14,197,000USD——-12,909,000USD—-24,000USD1,765,000USD
    Other Cashflows From Financing Activities390,829,000USD1,058,000USD—432,000USD21,000USD539,000USD-659,000USD135,000USD
    Unclassified Operating Cash Flow3,864,000USD18,627,000USD——————
    Unclassified Investing Cash Flow9,813,000USD-12,947,000USD-1,250,000USD—12,934,000USD——-1,765,000USD
    Unclassified Financing Cash Flow-392,664,000USD19,121,000USD——————
    Issuance Of Capital Stock——————0USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income447,179,000USD23,383,000USD12,672,000USD-198,335,000USD-348,101,000USD-279,381,000USD-172,871,000USD-173,482,000USD
    Depreciation59,000USD280,000USD423,000USD515,000USD494,000USD374,000USD282,000USD88,000USD
    Stock Based Compensation64,670,000USD42,541,000USD37,933,000USD19,185,000USD61,274,000USD80,289,000USD11,335,000USD12,886,000USD
    Other Non Cash Items5,857,000USD2,576,000USD2,218,000USD4,112,000USD2,398,000USD3,998,000USD3,515,000USD3,939,000USD
    Change To Account Receivables-176,443,000USD-78,092,000USD-51,093,000USD1,389,000USD-1,389,000USD-6,000USD-11,000USD14,000USD
    Change To Inventory-33,452,000USD-66,851,000USD-36,938,000USD0USD-15,991,000USD6,000USD11,000USD—
    Change In Working Capital-194,537,000USD-109,297,000USD-84,659,000USD-1,647,000USD-12,216,000USD-19,757,000USD25,190,000USD27,763,000USD
    Total Cash From Operating Activities-24,772,000USD-40,517,000USD-31,413,000USD-176,170,000USD-295,634,000USD-214,507,000USD-132,806,000USD-128,925,000USD
    Capital Expenditures-214,000USD-45,000USD0USD-14,000USD-401,000USD-357,000USD-131,000USD-90,000USD
    Free Cash Flow-24,986,000USD-40,562,000USD-31,413,000USD-176,184,000USD-296,035,000USD-214,864,000USD-132,937,000USD-129,015,000USD
    Investments14,013,000USD-1,036,000USD-50,651,000USD-20,013,000USD69,000USD-24,510,000USD-718,000USD1,180,000USD
    Total Cashflows From Investing Activities13,799,000USD-1,036,000USD-50,651,000USD-20,013,000USD-332,000USD-24,510,000USD-718,000USD1,180,000USD
    Net Borrowings0USD137,262,000USD25,000,000USD-975,000USD38,984,000USD40,000,000USD29,192,000USD29,987,000USD
    Total Cash From Financing Activities-89,729,000USD128,527,000USD72,705,000USD-391,000USD41,419,000USD679,827,000USD204,213,000USD113,639,000USD
    Sale Purchase Of Stock-91,240,000USD-8,760,000USD0USD584,000USD2,435,000USD679,827,000USD175,021,000USD113,639,000USD
    Issuance Of Capital Stock0USD0USD46,296,000USD46,296,000USD2,219,000USD679,680,000USD175,021,000USD113,639,000USD
    Change In Cash-100,702,000USD86,974,000USD-9,359,000USD-196,574,000USD-254,547,000USD440,810,000USD70,689,000USD-14,106,000USD
    Begin Period Cash Flow181,192,000USD94,218,000USD103,577,000USD300,151,000USD554,698,000USD113,888,000USD43,199,000USD57,305,000USD
    End Period Cash Flow80,490,000USD181,192,000USD94,218,000USD103,577,000USD300,151,000USD554,698,000USD113,888,000USD43,199,000USD
    Other Cashflows From Investing Activities14,013,000USD-991,000USD—-19,999,000USD69,000USD-24,153,000USD-587,000USD1,270,000USD
    Other Cashflows From Financing Activities-89,729,000USD25,000USD1,409,000USD-20,013,000USD-800,000USD147,000USD-795,000USD113,639,000USD
    Unclassified Operating Cash Flow-348,000,000USD———————
    Unclassified Investing Cash Flow-14,013,000USD1,036,000USD—20,013,000USD—24,510,000USD—-1,180,000USD
    Unclassified Financing Cash Flow91,240,000USD—46,296,000USD20,013,000USD—-40,147,000USD—-143,626,000USD
    Change To Liabilities———-11,217,000USD-2,319,000USD-22,014,000USD23,806,000USD29,155,000USD
    Cash And Cash Equivalents Changes———-196,574,000USD-254,547,000USD440,810,000USD70,689,000USD-14,106,000USD
    Dividends Paid————0USD0USD0USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2025Yearly · 2025-12-31ProductLicense — Other Revenue3,592,000USD0001437749-26-006133
    FY 2025Yearly · 2025-12-31ProductLicense — Royalty5,615,000USD0001437749-26-006133
    FY 2025Yearly · 2025-12-31ProductLicense Revenue152,000USD0001437749-26-006133
    FY 2025Yearly · 2025-12-31ProductMilestone0USD0001437749-26-006133
    FY 2025Yearly · 2025-12-31ProductProduct606,928,000USD0001437749-26-006133
    Q1 2025Quarterly · 2025-03-31ProductLicense1,201,000USD0001437749-25-015804
    Q1 2025Quarterly · 2025-03-31ProductLicense Revenue38,000USD0001437749-25-015804
    Q1 2025Quarterly · 2025-03-31ProductMilestone0USD0001437749-25-015804
    Q1 2025Quarterly · 2025-03-31ProductOther Revenue558,000USD0001437749-25-015804
    Q1 2025Quarterly · 2025-03-31ProductProduct119,655,000USD0001437749-25-015804
    Q1 2025Quarterly · 2025-03-31ProductRoyalty605,000USD0001437749-25-015804
    FY 2024Yearly · 2024-12-31ProductLicense — Milestone12,500,000USD0001437749-26-006133
    FY 2024Yearly · 2024-12-31ProductLicense — Other Revenue1,823,000USD0001437749-26-006133
    FY 2024Yearly · 2024-12-31ProductLicense — Royalty801,000USD0001437749-26-006133
    FY 2024Yearly · 2024-12-31ProductLicense Revenue152,000USD0001437749-26-006133
    FY 2024Yearly · 2024-12-31ProductProduct313,728,000USD0001437749-26-006133
    Q4 2024Quarterly · 2024-12-31ProductLicense — Milestone0USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductLicense — Other Revenue0USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductLicense — Royalty389,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductLicense Revenue38,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct107,347,000USDLegacy provider
    Q3 2024Quarterly · 2024-09-30ProductLicense582,000USD0001437749-24-033948
    Q3 2024Quarterly · 2024-09-30ProductLicense Revenue38,000USD0001437749-24-033948
    Q3 2024Quarterly · 2024-09-30ProductMilestone0USD0001437749-24-033948
    Q3 2024Quarterly · 2024-09-30ProductOther Revenue315,000USD0001437749-24-033948
    Q3 2024Quarterly · 2024-09-30ProductProduct83,297,000USD0001437749-24-033948
    Q3 2024Quarterly · 2024-09-30ProductRoyalty229,000USD0001437749-24-033948
    Q2 2024Quarterly · 2024-06-30ProductLicense — Other Revenue682,000USD0001437749-24-025853
    Q2 2024Quarterly · 2024-06-30ProductLicense — Royalty150,000USD0001437749-24-025853
    Q2 2024Quarterly · 2024-06-30ProductLicense Revenue38,000USD0001437749-24-025853
    Q2 2024Quarterly · 2024-06-30ProductMilestone0USD0001437749-24-025853
    Q2 2024Quarterly · 2024-06-30ProductProduct72,596,000USD0001437749-24-025853
    Q1 2024Quarterly · 2024-03-31ProductLicense — Milestone12,500,000USD0001437749-25-015804
    Q1 2024Quarterly · 2024-03-31ProductLicense — Other Revenue415,000USD0001437749-25-015804
    Q1 2024Quarterly · 2024-03-31ProductLicense — Royalty33,000USD0001437749-25-015804
    Q1 2024Quarterly · 2024-03-31ProductLicense Revenue38,000USD0001437749-25-015804
    Q1 2024Quarterly · 2024-03-31ProductProduct50,488,000USD0001437749-25-015804
    FY 2023Yearly · 2023-12-31ProductLicense — Other Revenue1,504,000USD0001437749-26-006133
    FY 2023Yearly · 2023-12-31ProductLicense Revenue140,153,000USD0001437749-26-006133
    FY 2023Yearly · 2023-12-31ProductMilestone0USD0001437749-26-006133
    FY 2023Yearly · 2023-12-31ProductProduct92,005,000USD0001437749-26-006133
    FY 2023Yearly · 2023-12-31ProductRoyalty0USD0001437749-26-006133
    Q4 2023Quarterly · 2023-12-31ProductLicense — Other Revenue719,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductLicense Revenue39,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductMilestone0USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductProduct43,136,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductRoyalty0USDLegacy provider
    Q3 2023Quarterly · 2023-09-30ProductLicense — Other Revenue709,000USD0001437749-24-033948
    Q3 2023Quarterly · 2023-09-30ProductLicense Revenue140,038,000USD0001437749-24-033948
    Q3 2023Quarterly · 2023-09-30ProductMilestone0USD0001437749-24-033948
    Q3 2023Quarterly · 2023-09-30ProductProduct25,068,000USD0001437749-24-033948
    Q3 2023Quarterly · 2023-09-30ProductRoyalty0USD0001437749-24-033948
    Q2 2023Quarterly · 2023-06-30ProductLicense38,000USD0001437749-24-025853
    Q2 2023Quarterly · 2023-06-30ProductLicense Revenue38,000USD0001437749-24-025853
    Q2 2023Quarterly · 2023-06-30ProductMilestone0USD0001437749-24-025853
    Q2 2023Quarterly · 2023-06-30ProductOther Revenue0USD0001437749-24-025853
    Q2 2023Quarterly · 2023-06-30ProductProduct16,036,000USD0001437749-24-025853
    Q2 2023Quarterly · 2023-06-30ProductRoyalty0USD0001437749-24-025853
    FY 2022Yearly · 2022-12-31ProductMilestone0USD0001437749-25-005908
    FY 2022Yearly · 2022-12-31ProductOther Revenue152,000USD0001437749-25-005908
    FY 2022Yearly · 2022-12-31ProductProduct2,633,000USD0001437749-25-005908
    FY 2022Yearly · 2022-12-31ProductRoyalty0USD0001437749-25-005908
    FY 2021Yearly · 2021-12-31ProductOther Revenue152,000USD0001437749-24-006144
    FY 2021Yearly · 2021-12-31ProductProduct6,537,000USD0001437749-24-006144
    FY 2020Yearly · 2020-12-31ProductLicense152,000USD0001558370-22-002617
    FY 2020Yearly · 2020-12-31ProductProduct0USD0001558370-22-002617

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.